During this event, Synaps will be introduced to new potential partners. The event is organized by the Research Council of Norway, the French Institutes / Embassies in the Nordic countries and the French Norwegian Foundation and held in Oslo. This Horizon 2020 Health Brokerage Event will focus on rare diseases. Glioblastoma being a neoplastic rare disease, GBM photodynamic therapies will be presented with the aim to strengthen our team with new academic and industrial partnerships.
More info on the event web site.
More info on the event web site.
